Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Top Cited Papers
- 1 October 2015
- journal article
- review article
- Published by Elsevier BV in Brain Research Bulletin
- Vol. 119, 1-11
- https://doi.org/10.1016/j.brainresbull.2015.09.002
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cellsBMC Gastroenterology, 2012
- A Superoxide-Mediated Mitogen-Activated Protein Kinase Phosphatase-1 Degradation and c-Jun NH2-Terminal Kinase Activation Pathway for Luteolin-Induced Lung Cancer CytotoxicityMolecular Pharmacology, 2012
- Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanismsInternational Journal of Cancer, 2011
- Facile access to sterically hindered aryl ketones via carbonylative cross-coupling: application to the total synthesis of luteolinTetrahedron, 2011
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavoneProceedings of the National Academy of Sciences of the United States of America, 2010
- Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotypeJournal of Neuroinflammation, 2010
- The cortical innate immune response increases local neuronal excitability leading to seizuresBrain, 2009
- Luteolin as a therapeutic option for multiple sclerosisJournal of Neuroinflammation, 2009
- Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-βJournal of Neuroinflammation, 2009
- Luteolin inhibits myelin basic protein‐induced human mast cell activation and mast cell‐dependent stimulation of Jurkat T cellsBritish Journal of Pharmacology, 2008